Percutaneous Interventions in the Coagulopathic Patient

 

 Buy Article Permissions and Reprints

ABSTRACT

Interventional procedures in patients with coagulopathies carry a perceived risk of increased bleeding and complications. Acquired and inherited deficiencies of blood-clotting factors, thrombocytopenia and platelet dysfunction, and effect of anticoagulation are common problems encountered by practicing clinical interventional radiologists. In this article we review common coagulopathies, available data on percutaneous procedures in coagulopathic patients, and recommendations for periprocedure treatment.

REFERENCES

• 1 Rodgers R P, Levin J. A critical reappraisal of the bleeding time.  Semin Thromb Hemost. 1990;  16 1-20
  Article in Thieme ConnectPubMedGoogle Scholar
• 2 Favaloro E J. Clinical application of the PFA-100.  Curr Opin Hematol. 2002;  9 407-415
  CrossrefPubMedGoogle Scholar
• 3 Liu M C, Kessler C M. A systematic approach to the bleeding patient. In: Kitchens CS, Alving BA, Kessler CM Consultative Hemostasis and Thrombosis. Philadelphia; WB Saunders 2002: 27-39
  Google Scholar
• 4 Rao A K. Acquired qualitative platelet defects. In: Colman RW, Marder VJ, Clowes P, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 905-920
  Google Scholar
• 5 Stanworth S J, Brunskill S J, Hyde C H, McClelland D BL, Murphy M F. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.  Br J Haematol. 2004;  126 139-152
  CrossrefPubMedGoogle Scholar
• 6 McVay P A, Toy P TCY. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities.  Am J Clin Pathol. 1990;  94 747-753
  PubMedGoogle Scholar
• 7 Fisher N C, Mutimer D J. Central venous cannulation in patients with liver disease and coagulopathy-a prospective audit.  Intensive Care Med. 1999;  25 481-485
  CrossrefPubMedGoogle Scholar
• 8 McVay P A, Toy P T. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities.  Transfusion. 1991;  31 164-171
  CrossrefPubMedGoogle Scholar
• 9 Chowdhury P, Saayman A G, Paulua U, Findlay G P, Collins P W. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.  Br J Haematol. 2004;  125 69-73
  CrossrefPubMedGoogle Scholar
• 10 Youssef W I, Salazar F, Dasarathy S, Beddow T, Mullen K D. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study.  Am J Gastroenterol. 2003;  98 1391-1394
  CrossrefPubMedGoogle Scholar
• 11 Kuriyan M, Carson J L. Blood transfusion risks in the intensive care unit.  Crit Care Clin. 2004;  20 237-253
  CrossrefPubMedGoogle Scholar
• 12 Slichter S J. Relationship between platelet count and bleeding risk in thrombocytopenic patients.  Transfus Med Rev. 2004;  18 153-167
  CrossrefPubMedGoogle Scholar
• 13 Wallace M J, Narvios A, Lichtiger B et al.. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia.  J Vasc Interv Radiol. 2003;  14 323-327
  CrossrefPubMedGoogle Scholar
• 14 Vavricka S R, Walter R B, Irani S, Halter J, Schanz U. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion.  Ann Hematol. 2003;  82 570-573
  CrossrefPubMedGoogle Scholar
• 15 Ray Jr C E, Shenoy S S. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices.  Radiology. 1997;  204 97-99
  CrossrefPubMedGoogle Scholar
• 16 Kitchens C S. Surgery and hemostasis. In: Kitchens CS, Alving BA, Kessler CM Consultative Hemostasis and Thrombosis. Philadelphia; WB Saunders 2002: 463-480
  Google Scholar
• 17 Aster R H. Pooling of platelet in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia.  J Clin Invest. 1966;  45 645-657
  CrossrefPubMedGoogle Scholar
• 18 Mannucci P M. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.  Blood. 1997;  90 2515-2521
  PubMedGoogle Scholar
• 19 Rao A K, Ghosh S, Sun L et al.. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects: a double-blind placebo-controlled trial.  Thromb Haemost. 1995;  74 1071-1078
  PubMedGoogle Scholar
• 20 Reiter R A, Mayr F, Blazicek H et al.. Desmopressin antagonizes the in vitro platelet dysfunction induced by GpIIb/IIIa inhibitors and aspirin.  Blood. 2003;  102 4594-4599
  CrossrefPubMedGoogle Scholar
• 21 Lethagen S. Desmopressin-a haemostatic drug: state-of-the-art review.  Eur J Anaesthesiol Suppl. 1997;  14 1-9
  PubMedGoogle Scholar
• 22 Dickneite G, Metzner H, Pfeifer T, Kroez M, Witzke G. A comparison of fibrin sealants in relation to their in vitro and in vivo properties.  Thromb Res. 2003;  112 73-82
  CrossrefPubMedGoogle Scholar
• 23 Tock B, Drohan W, Hess J, Pusateri A, Holcomb J, MacPhee M. Haemophilia and advanced fibrin sealant technologies.  Haemophilia. 1998;  4 449-455
  CrossrefPubMedGoogle Scholar
• 24 Martinowitz U, Varon D, Jonas P et al.. Circumcision in hemophilia: the use of fibrin glue for local hemostasis.  J Urol. 1992;  148 855-857
  PubMedGoogle Scholar
• 25 Brady A P, Malone D E, Diegnan R W, O'Donovan N, McGrath F P. Fibrin sealant in interventional radiology: a preliminary evaluation.  Radiology. 1995;  196 573-578
  PubMedGoogle Scholar
• 26 DiMichele D M, Mirani G, Wilfredo Canchis P, Trost D W, Talal A H. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.  Haemophilia. 2003;  9 613-618
  CrossrefPubMedGoogle Scholar
• 27 Menzebach A, Cassens U, van Aken H, Booke M. Strategies to reduce perioperative blood loss related to non-surgical bleeding.  Eur J Anaesthesiol. 2003;  20 764-770
  PubMedGoogle Scholar
• 28 Key N S. Recombinant FVIIa for intractable hemorrhage: more questions than answers.  Transfusion. 2003;  43 1649-1651
  CrossrefPubMedGoogle Scholar
• 29 Friederich P W, Henny C P, Messelink E J et al.. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial.  Lancet. 2003;  361 201-205
  CrossrefPubMedGoogle Scholar
• 30 Deveras R AE, Kessler C M. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.  Ann Intern Med. 2002;  137 884-888
  CrossrefPubMedGoogle Scholar
• 31 Jeffers L, Chalasani N, Balart N, Pyrsopoulos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy.  Gastroenterology. 2002;  123 118-126
  CrossrefPubMedGoogle Scholar

Barbara A KonkleM.D. 

Associate Professor of Medicine, Hematology/Oncology

PMC, MAB 103, 39th and Market Street

Philadelphia, PA 19104